Synapse - Marina Shcherba

Results (24)

A nutritional management algorithm in older patients with locally advanced esophageal cancer

Meeting Abstract

Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A. J.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Ilson, D. H.; Won, E.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Clinical relevance of clonal hematopoiesis in metastatic gastrointestinal malignancies

Meeting Abstract

Diplas, B.; Ptashkin, R.; Cercek, A.; Yaeger, R.; Bolton, K. L.; Chalasani, S. B.; Desai, A. M.; Goldberg, Z.; Gu, P.; Li, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Journal Article

Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Park, W.; Bandlamudi, C.; Berger, M. F.; Kelsen, D. P.; Suehnholz, S. P.; Chakravarty, D.; more...
Cancer (2021)

Fulltext@MSK | Save

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma

Meeting Abstract

Ku, G. Y.; Wu, A. J. C.; Sihag, S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; Shcherba, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)

Meeting Abstract

Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma

Meeting Abstract

Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial

Journal Article

Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
Lancet Oncology (2020)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)

Meeting Abstract

Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save